Cerebrovascular Accident (CVA): Comprehensive Overview
Definition and Core Concept
CVA is a loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms lasting at least 24 hours after onset or leading to death. 1 This distinguishes it from transient ischemic attack (TIA), where symptoms resolve within 24 hours but still carry a stroke risk as high as 13% in the first 90 days. 1
Types of CVA
Ischemic Stroke (80-85% of cases)
Ischemic CVA results from arterial occlusion through five primary mechanisms:
- Thrombotic occlusion from atherosclerotic plaque rupture in extracranial or intracranial vessels 1
- Embolic stroke from thrombus formed on atherosclerotic plaques (most commonly from carotid arteries) 1
- Atheroembolism from cholesterol crystal or plaque debris 1
- Hypoperfusion from severe stenosis or occlusion reducing cerebral blood flow 1
- Arterial dissection with subintimal hematoma compromising the lumen 1
Hemorrhagic Stroke (15-20% of cases)
Hemorrhagic CVA occurs when blood vessel rupture causes:
- Intracerebral hemorrhage within brain parenchyma, basal ganglia, or other deep structures 1
- Subarachnoid hemorrhage in the space surrounding the brain 1
Cerebral Venous Thrombosis (CVT)
CVT is a distinct entity where thrombosis of cerebral veins or sinuses causes venous infarction or hemorrhage. 1 The superior sagittal sinus is most commonly involved (leading to headache, increased intracranial pressure, papilledema), followed by lateral sinus and deep venous system thrombosis. 1
Pathophysiology
Ischemic Cascade
When cerebral blood flow drops below critical thresholds, a cascade of cellular injury begins within minutes:
- Core infarct develops in areas with blood flow <10-12 mL/100g/min (irreversible damage within minutes) 2
- Penumbra surrounds the core with blood flow 12-20 mL/100g/min (potentially salvageable tissue for 3-6 hours) 2
- Cytotoxic edema from ATP depletion causes cell swelling visible on diffusion-weighted MRI within minutes 2
- Excitotoxicity from glutamate release, calcium influx, and free radical formation propagates injury 2
Hemorrhagic Mechanisms
Hemorrhagic transformation occurs when:
- Hypertension causes lipohyalinosis and microaneurysm formation in penetrating arteries 1
- Reperfusion of ischemic tissue with damaged blood-brain barrier leads to secondary hemorrhage 1
- Venous hypertension from CVT causes venous infarction with hemorrhagic conversion 1
Clinical Features by Vascular Territory
Anterior Circulation (Carotid Territory)
Middle Cerebral Artery (MCA) - Most Common:
- Contralateral hemiparesis and hemisensory loss (face and arm > leg) 1
- Aphasia if dominant hemisphere (left in 95% of right-handed, 70% of left-handed patients) 1
- Neglect and visuospatial deficits if non-dominant hemisphere 1
- Homonymous hemianopia from optic radiation involvement 1
- Gaze deviation toward the lesion 1
Anterior Cerebral Artery (ACA):
- Contralateral leg weakness and sensory loss > arm 1
- Abulia and executive dysfunction from frontal lobe involvement 1
- Urinary incontinence 1
Internal Carotid Artery:
- Combination of MCA and ACA territory signs 1
- Amaurosis fugax (transient monocular blindness) from retinal artery involvement 1
Posterior Circulation (Vertebrobasilar Territory)
Vertebrobasilar System:
- Vertigo, nausea, vomiting (acute vestibular syndrome) 1
- Diplopia and dysarthria 1
- Ataxia and gait instability 1
- Crossed sensory or motor findings (ipsilateral face, contralateral body) 1
- Altered consciousness if bilateral thalamic or brainstem involvement 1
Posterior Cerebral Artery (PCA):
- Homonymous hemianopia with macular sparing 1
- Visual agnosia and prosopagnosia 1
- Memory impairment if medial temporal involvement 1
Lacunar Syndromes (Small Vessel Disease)
Pure motor hemiparesis from internal capsule or pons lesion 1 Pure sensory stroke from thalamic lesion 1 Ataxic hemiparesis from pons or internal capsule 1 Dysarthria-clumsy hand syndrome from pontine base lesion 1
Common OPD Presentations
TIA (Transient Ischemic Attack)
TIA patients present with resolved symptoms but face 13% stroke risk in 90 days, with highest risk in first 7 days. 1 Common presentations include:
- Brief episodes of unilateral weakness or numbness (minutes to hours) 1
- Transient aphasia or dysarthria 1
- Monocular vision loss (amaurosis fugax) suggesting carotid disease 1
- Transient diplopia or vertigo suggesting posterior circulation 1
Critical pitfall: Up to 24% of patients with acute retinal artery occlusion have concurrent cerebral infarction on MRI, even without neurological symptoms. 1 These patients require urgent stroke workup.
Subacute Stroke Presentations
In the ISCVT registry, 56% of CVT patients had subacute onset (>48 hours to 30 days), with median delay to diagnosis of 7 days. 1
- Progressive hemiparesis over days to weeks 1
- Isolated severe headache (25% of CVT cases) without focal signs 1
- Headache with papilledema or sixth nerve palsy mimicking idiopathic intracranial hypertension 1
- Seizures (40% of CVT patients, much higher than arterial stroke) 1
Chronic Presentations
Patients may present months after unrecognized stroke with:
- Established hemiparesis or spasticity 3
- Vascular dementia from multiple lacunar infarcts 1
- Post-stroke epilepsy 3
- Depression and cognitive impairment 4
Diagnostic Approach in OPD
Immediate Assessment
Perform NIHSS (National Institutes of Health Stroke Scale) to quantify severity: 5
- NIHSS <15: optimal candidates for intervention 5
- NIHSS >15 with obtundation: poor outcomes with aggressive intervention 5
Neuroimaging Priority
Non-contrast CT head must be completed within 30 minutes to distinguish ischemic from hemorrhagic stroke. 5 However, CT misses up to 54% of acute ischemic strokes in first 24 hours. 1
MRI with diffusion-weighted imaging (DWI) is superior: 5
- Detects ischemia within minutes (cytotoxic edema) 2
- Identifies 19-25% of patients with retinal artery occlusion who have silent brain infarction 1
- More sensitive than CT for posterior fossa strokes 1
Vascular Imaging
For patients with TIA or minor stroke, urgent carotid evaluation within 1 week is essential because stroke risk is highest in first 7 days. 1
- Carotid duplex ultrasound as initial screening 1
- CTA or MRA if surgery/stenting considered 1
- Up to 70% of symptomatic retinal artery occlusion patients have significant carotid stenosis 1
Laboratory Evaluation
Essential initial tests: 1
- Complete blood count, chemistry panel, PT/aPTT 1
- Troponin and ECG (concurrent MI in 20-24% of retinal artery occlusion) 1
- Lipid panel and HbA1c 4
- D-dimer if CVT suspected (high sensitivity but poor specificity) 1
Thrombophilia screening for CVT: 1
- Protein C, Protein S, Antithrombin III 1
- Factor V Leiden, Prothrombin G20210A mutation 1
- Antiphospholipid antibodies 1
- Screen for underlying inflammatory disease, infection, malignancy 1
Risk Stratification
CHADS₂ Score for Embolic Risk
In atrial fibrillation ablation patients, periprocedural CVA occurred in: 6
Prior CVA history increases risk 9.5-fold for recurrent events. 6
High-Risk Populations
Cancer survivors face dramatically elevated CVA risk: 4
- Leukemia survivors: 6× higher risk than siblings 4
- Brain tumor survivors: 29× higher risk 4
50 Gy to prepontine cistern: hazard ratio 17.8 for cerebrovascular death 4
- Hodgkin lymphoma with neck/mediastinal radiation: 2.5× higher ischemic CVD risk 4
Critical Pitfalls to Avoid
Diagnostic Pitfalls
Posterior circulation strokes are frequently missed: 1
- 75-80% of patients with vertebrobasilar infarction causing acute vestibular syndrome have no focal neurological deficits 1
- HINTS examination (Head Impulse, Nystagmus, Test of Skew) by trained practitioners is 100% sensitive vs. 46% for early MRI 1
- CT misses small posterior fossa infarcts; MRI with DWI is essential 1
CVT masquerades as other conditions: 1
- Isolated headache without focal signs in 25% of cases 1
- Bilateral thalamic involvement causes altered consciousness without lateralizing signs 1
- Seizures at presentation (40% of CVT) may mislead toward primary seizure disorder 1
Retinal artery occlusion is a stroke equivalent: 1
- 19-25% have concurrent silent brain infarction on MRI 1
- 3-6% stroke risk in first 1-4 weeks 1
- Only one-third of ophthalmologists currently refer to emergency department 1
Management Pitfalls
Blood pressure management is counterintuitive: 5
- Avoid aggressive lowering unless >220/120 mmHg (permissive hypertension maximizes penumbral flow) 5
- Must be <185/110 mmHg before thrombolysis, then <180/105 mmHg for 24 hours post-treatment 5
Timing errors compromise outcomes: 5
- Door-to-needle time must be ≤30 minutes for rtPA 5
- Aspirin should wait 24 hours after thrombolysis (but start within 48 hours of stroke onset) 5
- CEA benefit diminishes with time; perform within 2 weeks of TIA/minor stroke 1
Secondary Prevention
Antiplatelet Therapy
Aspirin 160-300 mg within 48 hours of ischemic stroke (after 24 hours if thrombolysis given). 5 For maintenance, aspirin 81-325 mg daily or clopidogrel 75 mg daily. 1
Lipid Management
Initiate high-intensity statin therapy regardless of baseline cholesterol levels. 5, 4 This reduces recurrent stroke risk even in patients with normal lipids. 4
Anticoagulation
For atrial fibrillation, start anticoagulation after ruling out hemorrhagic transformation (typically after 24-48 hours). 5 Direct oral anticoagulants (DOACs) are preferred over warfarin for most patients. 4
For CVT, anticoagulate for 3-6 months: 1
- IV heparin (aPTT 1.5-2.0× control) or LMWH followed by warfarin (INR 2.0-3.0) 1
- Continue despite hemorrhagic transformation (venous hemorrhage improves with anticoagulation) 1
Blood Pressure Control
Start antihypertensive therapy 24-48 hours post-stroke (after acute phase). 5, 4 Target <140/90 mmHg for most patients, <130/80 mmHg for diabetics. 4
Lifestyle Modifications
Evidence-based dietary interventions: 4
- Increase vegetables, fruits, whole grains, and fiber 4
- Use liquid vegetable oils instead of solid fats 4
- Limit added sugars and sodium 4
- Choose low-fat dairy and lean meats 4
- Alcohol: ≤1 drink/day for women, ≤2 drinks/day for men 4
Prognosis
Even with optimal treatment, many patients with established vascular disease remain at >20-30% 10-year risk of recurrent events, representing an area of unmet medical need. 4 Among CVA survivors, 75% have learning difficulties or intellectual disability, one-third develop epilepsy, and all have associated cerebral palsy when stroke occurs prenatally. 3